Somatostatin receptor-3 mediated intracellular signaling and apoptosis is regulated by its cytoplasmic terminal

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 3, 2011, Pages 390-402

  War, Sajad A ^a   Somvanshi, Rishi K ^a   Kumar, Ujendra ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apoptosis; Cytoplasmic tail; G protein coupled receptor; Human somatostatin receptor 3; Photobleaching fluorescence resonance energy transfer; Somatostatin

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; CYCLINE; CYTOPLASM PROTEIN; CYTOPLASMIC TERMINAL; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN TYROSINE PHOSPHATASE; SOMATOSTATIN RECEPTOR 3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEK293; CELL SURFACE; CYTOPLASM; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NICK END LABELING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADENYLATE CYCLASE; AMINO ACID SEQUENCE; APOPTOSIS; CELL LINE; CELL PROLIFERATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOLECULAR SEQUENCE DATA; MUTATION; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECEPTORS, SOMATOSTATIN; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 78951479962     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.12.015     Document Type: Article

References (63)

1. Milligan G. New aspects of G-protein-coupled receptor signalling and regulation. Trends Endocrinol. Metab. 1998, 9:13-19.
2. Pierce K.L., Premont R.T., Lefkowitz R.J. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 2002, 3:639-650.
3. Blois T.M., Bowie J.U. G-protein-coupled receptor structures were not built in a day. Protein Sci. 2009, 18:1335-1342.
4. Milligan G., McGrath J.C. GPCR theme editorial. Br. J. Pharmacol. 2009, 158:1-4.
5. Patel Y.C. Somatostatin and its receptor family. Front. Neuroendocrinol. 1999, 20:157-198.
6. Reubi J.C., Waser B., Schaer J.C., Laissue J.A. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur. J. Nucl. Med. 2001, 28:836-846.
7. Rocheville M., Lange D.C., Kumar U., Patel S.C., Patel R.C., Patel Y.C. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 2000, 288:154-157.
8. Rocheville M., Lange D.C., Kumar U., Sasi R., Patel R.C., Patel Y.C. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J. Biol. Chem. 2000, 275:7862-7869.
9. Pfeiffer M., Koch T., Schroder H., Klutzny M., Kirscht S., Kreienkamp H.J., Hollt V., Schulz S. Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J. Biol. Chem. 2001, 276:14027-14036.
10. Grant M., Collier B., Kumar U. Agonist-dependent dissociation of human somatostatin receptor 2 dimers: a role in receptor trafficking. J. Biol. Chem. 2004, 279:36179-36183.
11. Grant M., Patel R.C., Kumar U. The role of subtype-specific ligand binding and the C-tail domain in dimer formation of human somatostatin receptors. J. Biol. Chem. 2004, 279:38636-38643.
12. Baragli A., Alturaihi H., Watt H.L., Abdallah A., Kumar U. Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 co-immunoprecipitation and fluorescence resonance energy transfer analysis. Cell. Signal. 2007, 19:2304-2316.
13. Grant M., Kumar U. The role of G-proteins in the dimerisation of human somatostatin receptor types 2 and 5. Regul. Pept. 2009.
14. Somvanshi R.K., Billova S., Kharmate G., Rajput P.S., Kumar U. C-tail mediated modulation of somatostatin receptor type-4 homo- and heterodimerizations and signaling. Cell. Signal. 2009, 21:1396-1414.
15. Terrillon S., Bouvier M. Roles of G-protein-coupled receptor dimerization. EMBO Rep. 2004, 5:30-34.
16. Prinster S.C., Hague C., Hall R.A. Heterodimerization of G protein-coupled receptors: specificity and functional significance. Pharmacol. Rev. 2005, 57:289-298.
17. Grant M., Alturaihi H., Jaquet P., Collier B., Kumar U. Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization. Mol. Endocrinol. 2008, 22:2278-2292.
18. Watt H.L., Kharmate G.D., Kumar U. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells. Cell. Signal. 2009, 21:428-439.
19. Nishimoto S., Nishida E. MAPK signalling: ERK5 versus ERK1/2. EMBO Rep. 2006, 7:782-786.
20. Lahlou H., Saint-Laurent N., Esteve J.P., Eychene A., Pradayrol L., Pyronnet S., Susini C. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation. J. Biol. Chem. 2003, 278:39356-39371.
21. Weckbecker G., Lewis I., Albert R., Schmid H.A., Hoyer D., Bruns C. Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat. Rev. Drug Discov. 2003, 2:999-1017.
22. Smalley K.S., Feniuk W., Sellers L.A., Humphrey P.P. The pivotal role of phosphoinositide-3 kinase in the human somatostatin sst(4) receptor-mediated stimulation of p44/p42 mitogen-activated protein kinase and extracellular acidification. Biochem. Biophys. Res. Commun. 1999, 263:239-243.
23. Lahlou H., Guillermet J., Hortala M., Vernejoul F., Pyronnet S., Bousquet C., Susini C. Molecular signaling of somatostatin receptors. Ann. NY Acad. Sci. 2004, 1014:121-131.
24. Sellers L.A. Prolonged activation of extracellular signal-regulated kinase by a protein kinase C-dependent and N17Ras-insensitive mechanism mediates the proliferative response of G(i/o)-coupled somatostatin sst(4) receptors. J. Biol. Chem. 1999, 274:24280-24288.
25. Weiss R.E., Reddi A.H., Nimni M.E. Somatostatin can locally inhibit proliferation and differentiation of cartilage and bone precursor cells. Calcif. Tissue Int. 1981, 33:425-430.
26. Sharma K., Patel Y.C., Srikant C.B. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol. Endocrinol. 1996, 10:1688-1696.
27. Sharma K., Srikant C.B. G protein coupled receptor signaled apoptosis is associated with activation of a cation insensitive acidic endonuclease and intracellular acidification. Biochem. Biophys. Res. Commun. 1998, 242:134-140.
28. Sharma K., Patel Y.C., Srikant C.B. C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest. Mol. Endocrinol. 1999, 13:82-90.
29. Liu D., Martino G., Thangaraju M., Sharma M., Halwani F., Shen S.H., Patel Y.C., Srikant C.B. Caspase-8-mediated intracellular acidification precedes mitochondrial dysfunction in somatostatin-induced apoptosis. J. Biol. Chem. 2000, 275:9244-9250.
30. Rohrer S.P., Schaeffer J.M. Identification and characterization of subtype selective somatostatin receptor agonists. J. Physiol. Paris 2000, 94:211-215.
31. Hukovic N., Panetta R., Kumar U., Patel Y.C. Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): subtype selective internalization or upregulation. Endocrinology 1996, 137:4046-4049.
32. Lopez F., Esteve J.P., Buscail L., Delesque N., Saint-Laurent N., Vaysse N., Susini C. Molecular mechanisms of antiproliferative effect of somatostatin: involvement of a tyrosine phosphatase. Metabolism 1996, 45:14-16.
33. J. Cordoba-Chacon, M.D. Gahete, M. Duran-Prado, A.I. Pozo-Salas, M.M. Malagon, F. Gracia-Navarro, R.D. Kineman, R.M. Luque and J.P. Castano, Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents, Cell Mol. Life Sci., 67, 1147-63.
34. Srikant C.B., Patel Y.C. Somatostatin: Basic and Clinical Status 1987, Plenum Publishing Corp., New York.
35. Hukovic N., Panetta R., Kumar U., Rocheville M., Patel Y.C. The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase and in mediating desensitization and internalization. J. Biol. Chem. 1998, 273:21416-21422.
36. Strader C.D., Fong T.M., Graziano M.P., Tota M.R. The family of G-protein-coupled receptors. FASEB J. 1995, 9:745-754.
37. Gether U., Johansen T.E., Snider R.M., Lowe J.A., Emonds-Alt X., Yokota Y., Nakanishi S., Schwartz T.W. Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptor. Regul. Pept. 1993, 46:49-58.
38. Schwartz T.W., Rosenkilde M.M. Is there a 'lock' for all agonist 'keys' in 7TM receptors?. Trends Pharmacol. Sci. 1996, 17:213-216.
39. Greenwood M.T., Hukovic N., Kumar U., Panetta R., Hjorth S.A., Srikant C.B., Patel Y.C. Ligand binding pocket of the human somatostatin receptor 5: mutational analysis of the extracellular domains. Mol. Pharmacol. 1997, 52:807-814.
40. Roth A., Kreienkamp H.J., Meyerhof W., Richter D. Phosphorylation of four amino acid residues in the carboxyl terminus of the rat somatostatin receptor subtype 3 is crucial for its desensitization and internalization. J. Biol. Chem. 1997, 272:23769-23774.
41. Liu Q., Cescato R., Dewi D.A., Rivier J., Reubi J.C., Schonbrunn A. Receptor signaling and endocytosis are differentially regulated by somatostatin analogs. Mol. Pharmacol. 2005, 68:90-101.
42. Cescato R., Schulz S., Waser B., Eltschinger V., Rivier J.E., Wester H.J., Culler M., Ginj M., Liu Q., Schonbrunn A., Reubi J.C. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. J. Nucl. Med. 2006, 47:502-511.
43. Sharif N., Gendron L., Wowchuk J., Sarret P., Mazella J., Beaudet A., Stroh T. Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2. Endocrinology 2007, 148:2095-2105.
44. Liu Q., Dewi D.A., Liu W., Bee M.S., Schonbrunn A. Distinct phosphorylation sites in the SST2A somatostatin receptor control internalization, desensitization, and arrestin binding. Mol. Pharmacol. 2008, 73:292-304.
45. Romano C., Yang W.L., O'Malley K.L. Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J. Biol. Chem. 1996, 271:28612-28616.
46. Bai M., Trivedi S., Brown E.M. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J. Biol. Chem. 1998, 273:23605-23610.
47. Chabry J., Botto J.M., Nouel D., Beaudet A., Vincent J.P., Mazella J. Thr-422 and Tyr-424 residues in the carboxyl terminus are critical for the internalization of the rat neurotensin receptor. J. Biol. Chem. 1995, 270:2439-2442.
48. Thomas W.G., Baker K.M., Motel T.J., Thekkumkara T.J. Angiotensin II receptor endocytosis involves two distinct regions of the cytoplasmic tail. A role for residues on the hydrophobic face of a putative amphipathic helix. J. Biol. Chem. 1995, 270:22153-22159.
49. Jockers R., Da Silva A., Strosberg A.D., Bouvier M., Marullo S. New molecular and structural determinants involved in beta 2-adrenergic receptor desensitization and sequestration. Delineation using chimeric beta 3/beta 2-adrenergic receptors. J. Biol. Chem. 1996, 271:9355-9362.
50. Hipkin R.W., Friedman J., Clark R.B., Eppler C.M., Schonbrunn A. Agonist-induced desensitization, internalization, and phosphorylation of the sst2A somatostatin receptor. J. Biol. Chem. 1997, 272:13869-13876.
51. Venkatesan S., Petrovic A., Locati M., Kim Y.O., Weissman D., Murphy P.M. A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression. J. Biol. Chem. 2001, 276:40133-40145.
52. Hukovic N., Rocheville M., Kumar U., Sasi R., Khare S., Patel Y.C. Agonist-dependent up-regulation of human somatostatin receptor type 1 requires molecular signals in the cytoplasmic C-tail. J. Biol. Chem. 1999, 274:24550-24558.
53. Yasuda K., Rens-Domiano S., Breder C.D., Law S.F., Saper C.B., Reisine T., Bell G.I. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase. J. Biol. Chem. 1992, 267:20422-20428.
54. Barbieri F., Pattarozzi A., Gatti M., Porcile C., Bajetto A., Ferrari A., Culler M.D., Florio T. Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2. Endocrinology 2008, 149:4736-4746.
55. Nishida E., Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 1993, 18:128-131.
56. Hubina E., Nanzer A.M., Hanson M.R., Ciccarelli E., Losa M., Gaia D., Papotti M., Terreni M.R., Khalaf S., Jordan S., Czirjak S., Hanzely Z., Nagy G.M., Goth M.I., Grossman A.B., Korbonits M. Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours. Eur. J. Endocrinol. 2006, 155:371-379.
57. Berra E., Diaz-Meco M.T., Moscat J. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J. Biol. Chem. 1998, 273:10792-10797.
58. Hipkin R.W., Liu X., Ascoli M. Truncation of the C-terminal tail of the follitropin receptor does not impair the agonist- or phorbol ester-induced receptor phosphorylation and uncoupling. J. Biol. Chem. 1995, 270:26683-26689.
59. Sun Y., McGarrigle D., Huang X.Y. When a G protein-coupled receptor does not couple to a G protein. Mol. Biosyst. 2007, 3:849-854.
60. Lasfer M., Vadrot N., Schally A.V., Nagy A., Halmos G., Pessayre D., Feldmann G., Reyl-Desmars F.J. Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238. J. Hepatol. 2005, 42:230-237.
61. Thangaraju M., Sharma K., Leber B., Andrews D.W., Shen S.H., Srikant C.B. Regulation of acidification and apoptosis by SHP-1 and Bcl-2. J. Biol. Chem. 1999, 274:29549-29557.
62. Lattuada D., Casnici C., Venuto A., Marelli O. The apoptotic effect of somatostatin analogue SMS 201-995 on human lymphocytes. J. Neuroimmunol. 2002, 133:211-216.
63. Saito Y., Tetsuka M., Saito S., Imai K., Yoshikawa A., Doi H., Maruyama K. Arginine residue 155 in the second intracellular loop plays a critical role in rat melanin-concentrating hormone receptor 1 activation. Endocrinology 2005, 146:3452-3462.